Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation - A Prospective, Randomized, Controlled, Open, Cross-over, Phase II, Single-center Pilot Study [BiPhox-Trial]

NCT04071171 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT04071171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04071171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation - A Prospective, Randomized, Controlled, Open, Cross-over, Phase II, Single-center Pilot Study [BiPhox-Trial]
Lead sponsor
Medical University Innsbruck
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2020
Completion date
March 11, 2024
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, anticoagulation, biphozyl, continuous renal replacement therapy, continuous veno-venous hemofiltration, critically ill, phoxilium, regional citrate anticoagulation, renal replacement therapy, replacement fluid